Categories Cancer

Study Results Appear to Support Larotrectinib Use in NTRK+ Lung Cancer

Study Results Appear to Support Larotrectinib Use in NTRK+ Lung Cancer Frequent and durable antitumor responses as well as extended survival were noted with the use of larotrectinib (Vitrakvi) in patients with NTRK gene fusion–positive advanced lung cancer, and these benefits extended to patients with central nervous system (CNS) metastases.1 Results were collected from 14 […]

Read More
Categories Multiple Myeloma

Fate Therapeutics (FATE) to Release Quarterly Earnings on Wednesday

Fate Therapeutics (FATE) to Release Quarterly Earnings on Wednesday Fate Therapeutics (NASDAQ:FATE) is set to issue its quarterly earnings data after the market closes on Wednesday, February 24th. Analysts expect the company to announce earnings of ($0.38) per share for the quarter. Shares of FATE stock opened at $110.18 on Friday. The stock has a […]

Read More
Categories Multiple Myeloma

RCSI’s new Pathology Chair reveals hi-tech vision

RCSI’s new Pathology Chair reveals hi-tech vision Prof Siobhan Glavey enthused by latest developments in cancer diagnostics and precision medicine The new Chair and Professor in the Department of Pathology at the RCSI University of Medicine and Health Sciences has vowed to help her students become “healthcare experts of the future” by giving them access […]

Read More
Categories Multiple Myeloma

Dr Tony Holohan’s wife Emer dies following long battle with illness

Dr Tony Holohan’s wife Emer dies following long battle with illness DR TONY Holohan’s wife, Emer, has died following a long battle with illness.  Tributes have flooded in for Dr Emer, who passed away at Our Lady’s Hospice in Harold’s Cross, Dublin.  A beloved wife and mother of two, she was previously diagnosed with multiple myeloma, […]

Read More
Categories Cancer

Choosing better lung cancer treatments with machine learning

Choosing better lung cancer treatments with machine learning © iStock-Jackie Niam Researchers say that machine learning could help guide healthcare workers’ treatment decisions for lung cancer patients after developing a model that is 71% more accurate at predicting survival expectancy of patients. A team of Penn State Great Valley researchers conducted a study in which […]

Read More
Categories Multiple Myeloma

Actress Tamannaah’s pledge to help Devika ‘Fightagainstcancer’ with Tring

Actress Tamannaah’s pledge to help Devika ‘Fightagainstcancer’ with Tring Mumbai (Maharashtra) [India], February 19 (ANI/NewsVoir): With a call for the generous hearts to step ahead and contribute, Tamannaah has associated with Tring’s Icons for Change initiative to support a cause that is extremely close to her heart. The actress went live to garner donations for […]

Read More
Categories Multiple Myeloma

Novel Additions Require Nuanced Treatment Selection in Relapsed/Refractory Myeloma

Novel Additions Require Nuanced Treatment Selection in Relapsed/Refractory Myeloma Knowledge of prior therapies a patient has received, adequate prophylactic treatment, and consistent monitoring for unique toxicities is necessary to ensure patients are able to derive optimal benefit from novel options that have explored in relapsed/refractory myeloma therapy, according to Parameswaran Hari, MD, MRCP. “My approach […]

Read More
Categories Multiple Myeloma

Octapharma: New Consensus Recommendations on Treatment of Secondary Antibody Deficiency …

Octapharma: New Consensus Recommendations on Treatment of Secondary Antibody Deficiency … LACHEN, Switzerland–(BUSINESS WIRE)–New expert consensus guidelines on the use of immunoglobulin replacement therapy (IgRT) in patients with haematological malignancy and secondary antibody deficiencies (SAD) were recently published in the European Journal of Haematology. The publication, sponsored by Octapharma, marks the first pan-European consensus guidance […]

Read More